Zhenshiming eye drops fail testing in 10 batches, prompting recall and scrutiny
AI Summary- Zhenshiming halted production and recalled non-compliant tobramycin and dexamethasone eye drops.
- Ten Zhenshiming lot numbers failed appearance and particle-size testing.
- The company said corrective measures must be completed before production and sales resume.